MAR 13, 2015 2:04 PM PDT

Alzheimer's Breakthrough Uses Ultrasound Technology

WRITTEN BY: Ilene Schneider
Queensland scientists have found that non-invasive ultrasound technology can be used to treat Alzheimer's disease and restore memory.

University of Queensland researchers discovered that the innovative drug-free approach breaks apart the neurotoxic amyloid plaques that result in memory loss and cognitive decline.

Welcoming the findings today at UQ's Queensland Brain Institute, Queensland Premier Annastacia Palaszczuk said they could have a wide impact for the community.

"The Government's $9 million investment into this technology was to drive discoveries into clinics, and today's announcement indicates that together with the Queensland Brain Institute, it was a worthwhile investment," Ms Palaszczuk said.

"I want my Government to encourage more of this type of innovative research.

"Our Advance Queensland initiative aims to increase research and discoveries like this and to put this state's research at the forefront internationally by supporting local researchers and helping to keep them in Queensland.

"These exciting findings will hopefully be of benefit to all Australians in the future."

QBI Founding Director Professor Perry Bartlett said the discovery - a result of ‘game-changing' work performed at the Queensland Brain Institute's Clem Jones Centre for Ageing Dementia Research - was made possible through the support of the State and Federal Governments and philanthropic support led by the Clem Jones Foundation.

"The farsighted investment of government and philanthropic partners has allowed us to build the research excellence and capacity required to make major discoveries such as this," Professor Perry Bartlett said.

"I believe the work opens up an entirely novel avenue for future therapeutic treatment."

Clem Jones Centre for Ageing Dementia Research director Professor Jürgen Götz said the new treatment method could revolutionise Alzheimer's treatment by restoring memory.

"We're extremely excited by this innovation of treating Alzheimer's without using drug therapeutics," Professor Götz said.

"The ultrasound waves oscillate tremendously quickly, activating microglial cells that digest and remove the amyloid plaques that destroy brain synapses.

"The word ‘breakthrough' is often mis-used, but in this case I think this really does fundamentally change our understanding of how to treat this disease, and I foresee a great future for this approach."

Alzheimer's affects more than two-thirds of dementia patients, and approximately a quarter of a million Australians.

The total number of dementia cases in Australia is expected to rise to 900,000 by 2050.

"With an ageing population placing an increasing burden on the health system, an important factor is cost, and other potential drug treatments using antibodies will be expensive," Professor Götz said.

"In contrast, this method uses relatively inexpensive ultrasound and microbubble technology which is non-invasive and appears highly effective.

The approach is able to temporarily open the blood-brain barrier, activating mechanisms that clear toxic protein clumps and restoring memory functions.

"With our approach the blood-brain barrier's opening is only temporary for a few hours, so it quickly restores its protective role," Professor Götz said.

Research has been conducted using mice with an Alzheimer's model, with the next step being to scale the research in higher animal models ahead of human clinical trials, which are at least two years away.

"This treatment restored memory function to the same level of normal healthy mice," Professor Götz said.

"We're also working on seeing whether this method clears toxic protein aggregates in neurodegenerative diseases other than Alzheimer's and whether this also restores executive functions, including decision-making and motor control."

Source: University of Queensland
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAR 01, 2020
Neuroscience
MAR 01, 2020
AI Robot Boosts Social Skills in Autistic Children
A team of researchers from the University of Southern California have developed a “socially assistive robot” ...
MAR 01, 2020
Cardiology
MAR 01, 2020
Vegetarian Diet May Reduce Stroke Risk
Stroke is the world’s second leading cause of death. Now, researchers from Tzu Chi University in Hualien, Taiwan h ...
MAR 03, 2020
Neuroscience
MAR 03, 2020
Scientists Use Electrical Pulses to Switch Consciousness On and Off in Monkeys
Researchers from the University of Wisconsin-Madison have found that it’s possible to wake a monkey out of a deepl ...
APR 30, 2020
Cannabis Sciences
APR 30, 2020
Why Cannabis Users Don't Remember Their Dreams
Studies show that cannabis can improve the duration and quality of sleep. It’s thus no surprise that many use the ...
MAY 08, 2020
Neuroscience
MAY 08, 2020
Centenarians are Sharper than Those 25 Years Younger
Researchers at the University of New South Wales have found that those aged 95 and older have more activity between the ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
FDA Fast Tracks Vaccine for COVID-19
Biopharmaceutical company, Moderna, has announced that the US Food and Drug Administration has approved its experimental ...
Loading Comments...